Association between the cytotoxic T-lymphocyte antigen 4-318C/T polymorphism and malignant tumor risk

Biomedical Reports - Tập 5 Số 1 - Trang 93-100 - 2016
Taiming Li1, Chengdi Wang2, ZHENJU REN3, Yulin Ji1, Chang Xu1, Bing Xiao1, Min Liu1
1Department of Pediatric Surgery, West China Medical School, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
2Department of Respiratory Medicine, West China Medical School, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
3Department of Urinary Surgery, West China Medical School, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bredberg, 2011, Cancer: More of polygenic disease and less of multiple mutations? A quantitative viewpoint, Cancer, 117, 440, 10.1002/cncr.25440

Wong, 2006, Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma, J Oral Pathol Med, 35, 51, 10.1111/j.1600-0714.2005.00377.x

Ramakrishnan, 2013, Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer, Cancer Immunol Immunother, 62, 405, 10.1007/s00262-012-1390-6

Zhang, 2011, Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: A meta-analysis, Cancer, 117, 4312, 10.1002/cncr.25979

Ghaderi, 2011, CTLA4 gene variants in autoimmunity and cancer: A comparative review, Iran J Immunol, 8, 127

Sun, 2008, Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer, Cancer Res, 68, 7025, 10.1158/0008-5472.CAN-08-0806

Cheng, 2006, Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma, J Clin Oncol, 24, 3483, 10.1200/JCO.2005.05.5434

Erfani, 2006, Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer, Cancer Genet Cytogenet, 165, 114, 10.1016/j.cancergencyto.2005.07.020

Wang, 2007, Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population, BMC Cancer, 7, 173, 10.1186/1471-2407-7-173

Su, 2007, CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women, Carcinogenesis, 28, 1237, 10.1093/carcin/bgm043

Hadinia, 2007, CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers, J Gastroenterol Hepatol, 22, 2283, 10.1111/j.1440-1746.2007.04862.x

Li, 2009, Association between CTLA-4 gene promoter region polymorphisms at positions −1661 and −318 and gastric cancer, Clin J Gastroenterol, 14, 332

Khaghanzadeh, 2010, CTLA4 gene variations and haplotypes in patients with lung cancer, Cancer Genet Cytogenet, 196, 171, 10.1016/j.cancergencyto.2009.09.001

Rahimifar, 2010, ctla-4 gene variations may influence cervical cancer susceptibility, Gynecol Oncol, 119, 136, 10.1016/j.ygyno.2010.06.006

Liu, 2011, Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma, DNA Cell Biol, 30, 1051, 10.1089/dna.2011.1269

Jiang, 2011, Single nucleotide polymorphisms of CTLA4 gene and their association with human cervical cancer, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 28, 313

Yang, 2012, Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to Ewing's sarcoma, Genet Test Mol Biomarkers, 16, 1236, 10.1089/gtmb.2012.0129

Gokhale, 2013, CTLA-4 gene polymorphism at position +49 A>G in exon 1: A risk factor for cervical cancer in Indian women, Cancer Genet, 206, 154, 10.1016/j.cancergen.2013.04.003

Feng, 2013, Cytotoxic T-lymphocyte antigen-4 genetic variants and risk of Ewing's sarcoma, Genet Test Mol Biomarkers, 17, 458, 10.1089/gtmb.2012.0488

Bharti, 2013, Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population, Hum Immunol, 74, 348, 10.1016/j.humimm.2012.12.008

Liu, 2013, Genetic variations in CTLA-4, TNF-α, and LTA and susceptibility to T-cell lymphoma in a Chinese population, Cancer Epidemiol, 37, 930, 10.1016/j.canep.2013.08.011

Jaiswal, 2014, Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population, Mol Biol Rep, 41, 799, 10.1007/s11033-013-2919-2

Xiong, 2014, Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer, Int Immunopharmacol, 18, 71, 10.1016/j.intimp.2013.10.018

Hui, 2014, Polymorphism analysis of CTLA-4 in childhood acute lymphoblastic leukemia, Pak J Pharm Sci, 27, 1005

Cheng, 2015, LTA + 252A > G polymorphism is associated with risk of nasal NK/T-cell lymphoma in a Chinese population: A case-control study, BMC Cancer, 15, 480, 10.1186/s12885-015-1506-4

Wang, 2015, The correlation of cytotoxic T lymphocyte antigen 4 polymorphisms with occurrence of cervical cancer, Pract J Clin Med, 12, 77

Jackson, 2012, Quantifying the impact of between-study heterogeneity in multivariate meta-analyses, Stat Med, 31, 3805, 10.1002/sim.5453

Leach, 1996, Enhancement of antitumor immunity by CTLA-4 blockade, Science, 271, 1734, 10.1126/science.271.5256.1734

Xu, 2014, Association of CTLA4 gene polymorphism (rs5742909) with cervical cancer: A meta-analysis, Tumour Biol, 35, 1605, 10.1007/s13277-013-1221-1